Mr Kael Kuster, MD | |
2401 S 31st St, Temple, TX 76508-0001 | |
(254) 724-2111 | |
Not Available |
Full Name | Mr Kael Kuster |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2401 S 31st St, Temple, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124438999 | NPI | - | NPPES |
583944 | Other | TX | TEXAS MEDICAL BOARD PHYSICIAN IN TRAINING |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | BP10050879 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Kael Kuster, MD 2401 S 31st St, Temple, TX 76508-0001 Ph: () - | Mr Kael Kuster, MD 2401 S 31st St, Temple, TX 76508-0001 Ph: (254) 724-2111 |
News Archive
Epileptic fits are like thunderstorms raging in the brain: Nerve cells excite each other in an uncontrolled way so that strong, rhythmic electrical discharges sweep over whole brain regions. In the wake of such a seizure, the nerve cells are severely affected, and permanent damage is possible. The glia, a class of cells that surround the neurons in the brain, was long suspected to contribute to the damaging effects of epilepsy.
Cell Therapy Ltd. today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcelâ„¢ (immuno-modulatory progenitor [iMP] cells) to Daiichi Sankyo.
Axovant Sciences Ltd., a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced the first patients screened in MINDSET, a confirmatory global phase 3 study of Axovant's lead product candidate, RVT-101. Axovant also announced that the company and the U.S. Food and Drug Administration have agreed to a Special Protocol Assessment (SPA) supporting this phase 3 program.
As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.
› Verified 4 days ago
Mumtaz Suleman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Solomon Seffia Williams, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1901 S 1st St, Ctvhcs 116a, Temple, TX 76504 Phone: 254-743-2867 | |
Seyed Pouyan Jalali, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Arash Shadman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
George B Creel, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Helen A. Zaphiris, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Kenyatta Mie Jones, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Department Of Psychiatry, Temple, TX 76508 Phone: 254-724-1768 |